Visugromab
Product Specifications
CAS Number
2556646-63-8
Target
PD-1/PD-L1, TGF-beta/Smad
Related Pathways
Apoptosis, Stem Cells, Cell Cycle/Checkpoint, Immunology/Inflammation
Purity
0.988
Bioactivity
Visugromab (CTL-002) is a monoclonal antibody that targets and neutralises GDF-15. Visugromab exhibits synergistic anticancer activity with the anti-PD1 antibody Nivolumab, making it suitable for PD-1/PD-L1 recurrent/refractory metastatic solid tumours.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038941-ML550 100 µL
NFKBIB, CT (NFKBIB, IKBB, TRIP9, NF-kappa-B inhibitor beta, I-kappa-B-beta, Thyroid receptor-interacting protein 9) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
H3292 96 Tests
Sterol regulatory element-binding protein 1 (SREBF1) Porcine ELISA Kit
Sign In for Pricing
View Details